| |
| |
|
| Insider
Information: |
Kailian Vaughn M |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
303,148 |
|
|
Indirect Shares
|
6,513,709 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$26,023,192 |
|
|
| Total
Shares |
6,816,857 |
|
|
| Total
Value |
$26,023,192 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Millennium Pharmaceuticals Inc |
MLNM |
Director |
2004-06-21 |
303,148 |
2004-06-21 |
1,146 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
10% Owner |
|
0 |
2014-02-10 |
2,413,819 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
|
0 |
2013-06-26 |
180,505 |
Premium* |
|
|
Trivascular Technologies, Inc. |
TRIV |
10% Owner |
2014-04-22 |
0 |
2014-04-22 |
1,776,692 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
10% Owner |
2014-06-06 |
0 |
2014-06-06 |
2,141,547 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDUS |
Radius Health Inc. |
10% Owner |
– – • |
2014-06-06 |
4 |
A |
$0.00 |
$0 |
I/I |
393,802 |
2,141,547 |
0 |
- |
|
| RDUS |
Radius Health Inc. |
10% Owner |
– – • |
2014-06-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,747,745 |
1,747,745 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
10% Owner |
– – • |
2014-04-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,776,692 |
1,776,692 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
10% Owner |
– – • |
2014-02-10 |
4 |
S |
$29.25 |
$13,649,981 |
I/I |
(466,666) |
2,413,819 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
10% Owner |
– – • |
2013-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
180,505 |
|
- |
|
| EPZM |
Epizyme, Inc. |
10% Owner |
– – • |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,702,154 |
2,880,485 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
10% Owner |
– – • |
2013-05-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
178,331 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Director |
– • – |
2004-06-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
730 |
303,148 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Director |
– • – |
2004-06-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,400 |
303,878 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Director |
– • – |
2004-01-30 |
4 |
S |
$17.58 |
$1,757,500 |
D/D |
(100,000) |
308,278 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Vice Chairperson |
• • – |
2003-11-07 |
4 |
OE |
$8.04 |
$476,274 |
D/D |
59,238 |
408,278 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
